Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Markt

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
JAMA Oncology|January 25, 2019
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell TumorsSaud H AlDubayan, Louise C Pyle, Marija Gamulin, et al.
The Prostate|August 14, 2015
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)Sarah C Markt, Irene M Shui, Robert H Unger, et al.
Journal of the National Cancer Institute|October 3, 2020
Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic ResearchLauren M Hurwitz, Ilir Agalliu, Demetrius Albanes, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
JAMA Oncology|January 25, 2019
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell TumorsSaud H AlDubayan, Louise C Pyle, Marija Gamulin, et al.
The Prostate|August 14, 2015
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)Sarah C Markt, Irene M Shui, Robert H Unger, et al.
Journal of the National Cancer Institute|October 3, 2020
Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic ResearchLauren M Hurwitz, Ilir Agalliu, Demetrius Albanes, et al.
Pageof 9